A Texas college student spent months suffering from unexplained seizures and psychosis before UTHealth Houston doctors determined she had a rare condition.

After surgery, some older adults don't simply recover—they unravel. Confusion, inattention, and agitation can set in, a condition known as postoperative delirium. For patients already living with ...

Detailed price information for Bright Minds Biosciences Inc (DRUG-CN) from The Globe and Mail including charting and trades.

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

In other recent news, Bright Minds Biosciences Inc. is set to announce the results of its Phase 2 trial for BMB-101, targeting drug-resistant absence seizures and developmental and epileptic ...

The Phase 2 open-label, multicenter study evaluated safety, tolerability and efficacy of BMB-101 in adults with drug-resistant Absence Seizures and DEE. A total of 24 patients were enrolled, exceeding ...

Bright Minds Biosciences ( (TSE:DRUG)) has issued an update. On January 5, 2026, Bright Minds Biosciences announced plans to report topline results from its Phase 2 trial of BMB-101 in patients with ...